share_log

Demystifying Definitive Healthcare: Insights From 9 Analyst Reviews

Demystifying Definitive Healthcare: Insights From 9 Analyst Reviews

從9位分析師的評價中解讀Definitive Healthcare
Benzinga ·  07/31 14:01
In the last three months, 9 analysts have published ratings on Definitive Healthcare (NASDAQ:DH), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月裏,9個分析師對Definitive Healthcare(NASDAQ:DH)進行了評級,提供了從看好到看淡的多元化觀點。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近評級的精簡視圖,顯示了過去30天的不同情緒,並將其與前幾個月進行比較。
Analysts have recently evaluated Definitive Healthcare and provided 12-month price targets. The average target is $7.22, accompanied by a high estimate of $9.50 and a low estimate of $5.00. Observing a downward trend, the current average is 23.52% lower than the prior average price target of $9.44.
最近分析師對Definitive Healthcare進行了評估,並提供了12個月的目標價。平均目標價格爲7.22美元,最高估值爲9.50美元,最低估值爲5.00美元。觀察到價格下跌的趨勢,當前的平均價格比之前的目標價格9.44美元低了23.52%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
In examining...
通過...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論